GlassScriptPhysician profile
William Stoddard
NPI 1831549187
$7,137.92
in general payments reported to CMS, 2019-2025
10 companies · $200 in 2025
The $200 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $692 · 2020: $200 · 2021: $29.58 · 2024: $6,016 · 2025: $200.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Debt Forgiveness: $5,914 · Food and Beverage: $302.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Debt Forgiveness | $5,913.93 |
| Food and Beverage | $302.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Carl Zeiss Meditec Digital Innovations LLC | $5,913.93 | 2024 | Veracity Surgical |
| Alcon Vision LLC | $771.29 | 2019-2025 | Hydrus Microstent |
| Regeneron Healthcare Solutions, INC. | $125.00 | 2019 | |
| Sight Sciences, INC. | $106.66 | 2020-2025 | Omni Surgical System, Sion Surgical Instrument |
| Glaukos Corporation | $88.69 | 2024 | Istent Trabecular Micro-Bypass System Model Is3 |
| Johnson & Johnson Surgical Vision, INC. | $32.50 | 2025 | Veritas Vision System |
| Allergan, INC. | $29.58 | 2021 | |
| Rxsight INC | $29.08 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Bausch & Lomb Americas INC. | $21.90 | 2025 | Miebo, Xiidra |
| Abbvie INC. | $19.29 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Stoddard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.